Cite

HARVARD Citation

    Morishita, M. et al. (2016). Exosome-based tumor antigens–adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA. Biomaterials. pp. 55-65. [Online]. 
  
Back to record